Stay updated on Amivantamab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4, updating the displayed revision label to Revision: v3.3.4.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a new release note 'Revision: v3.3.3' in the page footer. Removed the 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' release note.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page no longer shows the government funding status/operating status notice. This change does not affect the trial details, inclusion criteria, or listed locations.SummaryDifference0.4%

- Check75 days agoChange DetectedNo significant changes to the study details, outcomes, or enrollment are evident; only minor formatting or layout updates appear.SummaryDifference0.4%

- Check103 days agoChange DetectedCore content updated to v3.2.0 with a government funding status notice and operating details; previous v3.1.0 deletion indicates version upgrade.SummaryDifference2%

Stay in the know with updates to Amivantamab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Gastric Cancer Clinical Trial page.